J&J Will Sell Diagnostics Division to Carlyle Group

Jan 21, 2014


Johnson & Johnson said it would sell its ortho clinical diagnostics division to the Carlyle Group LP for $4.15 billion, shedding a slow-growing business to focus on more lucrative products. The unit includes laboratory diagnostics products and blood-transfusion-screening equipment, and it has operations in 130 countries. The acquisition is expected to be finalized in mid-2014. Read the full story

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments